Drug intelligence / Profile preview

Cyclofemina

Development stage
Unknown
Lead developer
MR Pharma
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Cyclofemina is a monthly injectable hormonal contraceptive containing a combination of medroxyprogesterone acetate (a progestogen) and estradiol cypionate (an estrogen). It is used to prevent pregnancy primarily by suppressing ovulation through the inhibition of gonadotropin secretion from the pituitary gland. The formulation is an aqueous suspension intended for intramuscular administration, typically providing effective contraceptive action for one month. In the context of clinical research by Galeno Desenvolvimento de Pesquisas Clínicas, Cyclofemina serves as the reference formulation for bioavailability and safety studies comparing it to other injectable contraceptives such as Depomês.

Brand names
Cyclofemina
Other names
medroxyprogesterone acetate + estradiol cypionate
02

Targets

RB1 (Retinoblastoma-associated Protein)ESR2 (ERβ)PR-A (Progesterone Receptor A)ESR1 (ERα)

Beyond the preview

Go deeper on Cyclofemina.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclofemina.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call